We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Veeva Systems (VEEV) Stock Dips While Market Gains: Key Facts
Read MoreHide Full Article
Veeva Systems (VEEV - Free Report) ended the recent trading session at $318.18, demonstrating a -1.5% change from the preceding day's closing price. This change lagged the S&P 500's 0.7% gain on the day. On the other hand, the Dow registered a gain of 0.28%, and the technology-centric Nasdaq increased by 0.83%.
The stock of provider of cloud-based software services for the life sciences industry has risen by 15.09% in the past month, leading the Medical sector's gain of 3.23% and the S&P 500's loss of 1.21%.
The investment community will be paying close attention to the earnings performance of Veeva Systems in its upcoming release. The company's upcoming EPS is projected at $2.33, signifying a 14.22% increase compared to the same quarter of the previous year. Simultaneously, our latest consensus estimate expects the revenue to be $933.79 million, showing a 15.11% escalation compared to the year-ago quarter.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $9.22 per share and revenue of $3.69 billion, indicating changes of +13.83% and +15.35%, respectively, compared to the previous year.
Investors might also notice recent changes to analyst estimates for Veeva Systems. These revisions typically reflect the latest short-term business trends, which can change frequently. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. Veeva Systems presently features a Zacks Rank of #3 (Hold).
In terms of valuation, Veeva Systems is currently trading at a Forward P/E ratio of 35.04. This signifies a premium in comparison to the average Forward P/E of 34.99 for its industry.
We can also see that VEEV currently has a PEG ratio of 1. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. The Medical Info Systems industry had an average PEG ratio of 3.25 as trading concluded yesterday.
The Medical Info Systems industry is part of the Medical sector. This group has a Zacks Industry Rank of 94, putting it in the top 39% of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.
View the Zacks #1 Rank List
Image: Bigstock
Veeva Systems (VEEV) Stock Dips While Market Gains: Key Facts
Veeva Systems (VEEV - Free Report) ended the recent trading session at $318.18, demonstrating a -1.5% change from the preceding day's closing price. This change lagged the S&P 500's 0.7% gain on the day. On the other hand, the Dow registered a gain of 0.28%, and the technology-centric Nasdaq increased by 0.83%.
The stock of provider of cloud-based software services for the life sciences industry has risen by 15.09% in the past month, leading the Medical sector's gain of 3.23% and the S&P 500's loss of 1.21%.
The investment community will be paying close attention to the earnings performance of Veeva Systems in its upcoming release. The company's upcoming EPS is projected at $2.33, signifying a 14.22% increase compared to the same quarter of the previous year. Simultaneously, our latest consensus estimate expects the revenue to be $933.79 million, showing a 15.11% escalation compared to the year-ago quarter.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $9.22 per share and revenue of $3.69 billion, indicating changes of +13.83% and +15.35%, respectively, compared to the previous year.
Investors might also notice recent changes to analyst estimates for Veeva Systems. These revisions typically reflect the latest short-term business trends, which can change frequently. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. Veeva Systems presently features a Zacks Rank of #3 (Hold).
In terms of valuation, Veeva Systems is currently trading at a Forward P/E ratio of 35.04. This signifies a premium in comparison to the average Forward P/E of 34.99 for its industry.
We can also see that VEEV currently has a PEG ratio of 1. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. The Medical Info Systems industry had an average PEG ratio of 3.25 as trading concluded yesterday.
The Medical Info Systems industry is part of the Medical sector. This group has a Zacks Industry Rank of 94, putting it in the top 39% of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.